Table 1.
Demographic and clinical data of the training and test cohorts.
PD | Older adults | |
---|---|---|
Training cohort | ||
N (females) | 5 (3) | 1 (1) |
Age (years) | 71 (4) | 51 |
UPDRS III (0–132) | 23 (10) | 3 (0) |
H&Y (0–5) | 2 (1) | 0 (0) |
LED (mg) | 713 (640) | (0) |
Test cohort | ||
N (females) | 20 (10) | 13 (6) |
Age (years) | 66 (9) | 60 (10) |
UPDRS III (0–132) | 32 (12) | 2 (4) |
H&Y (0–5) | 3 (1) | 0 (0) |
LED (mg) | 839 (622) | 0 (0) |
Data are shown as mean ± SD, except gender and observed turns.
H&Y, Hoehn & Yahr; LED, Levodopa equivalent dose; PD, Parkinson’s disease; UPDRS, Unified Parkinson’s Disease Rating Scale III, motor part of the revised Unified PD Rating scale.